Enhanced DNA damage-induced p53 peptide phosphorylation and cell-cycle arrest in Sjogren's syndrome cells

被引:9
|
作者
Henriksson, G [1 ]
Brant, M
Sallmyr, A
Fukushima, S
Manthorpe, R
Bredberg, A
机构
[1] Lund Univ, Malmo Univ Hosp, Sjogrens Syndrome Res Ctr, Dept Med Microbiol, S-20502 Malmo, Sweden
[2] Lund Univ, Malmo Univ Hosp, Sjogrens Syndrome Res Ctr, Dept Rheumatol, Malmo, Sweden
关键词
autoimmunity; DNA damage response; DNA-dependent protein kinase; Sjogren's syndrome;
D O I
10.1046/j.1365-2362.2002.00997.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Cells from primary Sjogren's syndrome (SS) patients have been reported to show alterations in DNA repair and p53 expression. The DNA-dependent protein kinase (DNA-PK) autoantigen may be involved in both of these alterations in relation to cellular DNA damage responses. We conducted this study of cell-cycle kinetics and p53 to find additional evidence for an abnormal stress response role in the pathogenesis of SS. Design DNA-dependent protein kinase activity, p53 peptide phosphorylation and p53 protein levels were determined in gamma-irradiated long-term T lymphocyte cultures. Cell-cycle progression of peripheral blood mononuclear cells was analysed with flow cytometry. Results No significant differences in the DNA-PK activities or p53 protein levels appeared between the SS patients and the healthy individuals. However, patients with the SS hallmark Ro/SS-A and La/SS-B autoantibodies showed enhancement of both p53 peptide phosphorylation (P = 0.036) and G1 cell-cycle arrest (P = 0.015) in response to gamma radiation. Conclusions Sjogren's syndrome cells express an enhanced G1 checkpoint function which may be mediated partly by p53 phosphorylation, suggesting that an abnormal stress response in SS is of relevance for the development of this autoimmune disease.
引用
收藏
页码:458 / 465
页数:8
相关论文
共 50 条
  • [1] A role for ATR in the DNA damage-induced phosphorylation of p53
    Tibbetts, RS
    Brumbaugh, KM
    Williams, JM
    Sarkaria, JN
    Cliby, WA
    Shieh, SY
    Taya, Y
    Prives, C
    Abraham, RT
    GENES & DEVELOPMENT, 1999, 13 (02) : 152 - 157
  • [2] P53 INVOLVEMENT IN CONTROL OF G2 EXIT OF THE CELL-CYCLE - ROLE IN DNA DAMAGE-INDUCED APOPTOSIS
    GUILLOUF, C
    ROSSELLI, F
    KRISHNARAJU, K
    MOUSTACCHI, E
    HOFFMAN, B
    LIEBERMANN, DA
    ONCOGENE, 1995, 10 (11) : 2263 - 2270
  • [3] Phosphorylation of Daxx by ATM Contributes to DNA Damage-Induced p53 Activation
    Tang, Jun
    Agrawal, Trisha
    Cheng, Qian
    Qu, Like
    Brewer, Michael D.
    Chen, Jiandong
    Yang, Xiaolu
    PLOS ONE, 2013, 8 (02):
  • [4] DNA damage-induced cell-cycle phase regulation of p53 and p21waf1 in normal and ATM-defective cells
    Delia, D
    Fontanella, E
    Ferrario, C
    Chessa, L
    Mizutani, S
    ONCOGENE, 2003, 22 (49) : 7866 - 7869
  • [5] DNA damage-induced cell-cycle phase regulation of p53 and p21waf1 in normal and ATM-defective cells
    Domenico Delia
    Enrico Fontanella
    Cristina Ferrario
    Luciana Chessa
    Shuki Mizutani
    Oncogene, 2003, 22 : 7866 - 7869
  • [6] P53 - A CELL-CYCLE REGULATOR ACTIVATED BY DNA-DAMAGE
    SELIVANOVA, G
    WIMAN, KG
    ADVANCES IN CANCER RESEARCH, VOL 66, 1995, 66 : 143 - 180
  • [7] DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
    Shieh, SY
    Ikeda, M
    Taya, Y
    Prives, C
    CELL, 1997, 91 (03) : 325 - 334
  • [8] Dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest
    Zhao, Zhen
    Dong, Qiongye
    Liu, Xuehui
    Wei, Lei
    Liu, Liyang
    Li, Yanda
    Wang, Xiaowo
    GENOMICS, 2020, 112 (02) : 1309 - 1317
  • [9] The influence of p53 transactivation and repression functions on abrogation of DNA damage-induced cell cycle arrest by UCN-01 in breast cancer cells.
    Kohn, EA
    Bresnick, E
    Direnzo, J
    Eastman, A
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6220S - 6220S
  • [10] Iso-suillin-induced DNA damage leading to cell cycle arrest and apoptosis arised from p53 phosphorylation in A549 cells
    Yan, Yongxin
    Yao, Shengjie
    Jia, Zhiqiang
    Zhao, Junxia
    Wang, Li'an
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 907